Physician profile
Jefferson Berryman
NPI 1275995714
$10,770.59
in general payments reported to CMS, 2019-2025
9 companies · $7,311 in 2025
The $7,311 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2021: $85.45 · 2022: $591 · 2023: $1,649 · 2024: $1,010 · 2025: $7,311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,500 · Food and Beverage: $3,255 · Travel and Lodging: $1,207 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,500.00 |
| Food and Beverage | $3,254.87 |
| Travel and Lodging | $1,207.33 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $6,261.60 | 2025 | Travoprost Intraocular Implant - Idose, Idosetr |
| Abbvie INC. | $2,206.70 | 2022-2025 | Durysta, Xen Glaucoma Treatment System |
| New World Medical,INC. | $1,070.91 | 2022-2025 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Alcon Vision LLC | $728.38 | 2019-2025 | Hydrus Microstent, Clareon, Constellation |
| Sight Sciences, INC. | $212.30 | 2022-2025 | Omni Surgical System |
| Rxsight INC | $143.16 | 2024-2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Johnson & Johnson Surgical Vision, INC. | $105.52 | 2024-2025 | Healon Duet Pro |
| Allergan, INC. | $30.02 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jefferson Berryman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.